Page last updated: 2024-08-03 07:56:59

pukalide

Description

pukalide: structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID21574603
CHEMBL ID300390
SCHEMBL ID1760554
MeSH IDM0415500

Synonyms (4)

Synonym
pukalide
CHEMBL300390
SCHEMBL1760554
methyl (2r,4s,6r,12s)-4-methyl-8-oxo-12-prop-1-en-2-yl-3,7,17-trioxatetracyclo[12.2.1.16,9.02,4]octadeca-1(16),9(18),14-triene-15-carboxylate

Bioassays (1)

Assay IDTitleYearJournalArticle
AID145335In vitro ability to inhibit the binding of [125I]alpha-bungarotoxin to nicotinic acetylcholine receptor on membranes prepared from the electric organs of Torpedo californica; Not active1991Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
ISSN: 0022-2623
Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists.

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
homarinenon-proteinogenic alpha-amino acid2007200717.0high000100
furanfurans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
2001201715.0high000110
perillyl alcohollimonene monoterpenoidplant metabolite;
volatile oil component
201720177.0high000010
lophotoxin2002200222.0high000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020